As of November 14, 2026, Ardent Health, Inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 27, 2026 to October 23, 2026 (Form 8-K, October 23, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Ardent Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-10-23
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-06-02
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-03-27
Ardent Health, Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-27 to 2026-10-23. Every row below is cited to the filing it comes from, and this page adds each new change as Ardent Health, Inc. files it.
Also on the record for Ardent Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 18, 2024 | IPO filing, Form 424B4 | $16 a share | IPO filings | Source |
| July 15, 2024 | IPO filing, Form S-1/A | $20 to $22 a share | IPO filings | Source |
| July 10, 2024 | IPO filing, Form S-1/A | — | IPO filings | Source |
| July 8, 2024 | IPO filing, Form S-1/A | $20 to $22 a share | IPO filings | Source |
Selling to them or working with them? See who runs Ardent Health, Inc. now and the warning signs.
Free to see. No signup.
Watch Ardent Health, Inc.
Get an email when Ardent Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Ardent Health, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Ardent Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ardent Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-23 | Reported | not named in the filing | 8-K, 2026-10-23 | ||
| 2026-06-02 | Reported | not named in the filing | 8-K, 2026-06-02 | ||
| 2026-03-27 | Reported | not named in the filing | 8-K, 2026-03-27 |
New leaders reset buying decisions — get the Full Report on Ardent Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Ardent Health, Inc., with the record behind each one.
Find candidates like senior executive at Ardent Health, Inc.Every change, in the filing's words
Reported
On October 19, 2026, following notice to Mr. Bonick and a hearing at which he was afforded an opportunity to be heard, the Board determined that facts and circumstances discovered after the Separation Date would have given the Company grounds to terminate Mr. Bonick's employment for "Cause" as of the Separation Date.
- As previously disclosed, Martin J. Bonick's employment as President and Chief Executive Officer of Ardent Health, Inc. (the "Company") and his service as a member of the Company's Board of Directors (the "Board") ended effective June 2, 2026 (the "Separation Date").
- In connection with his departure, Mr. Bonick and AHS Management Company, Inc. ("AHS"), a subsidiary of the Company, entered into a Separation Agreement and General Release, dated as of June 26, 2026 (the "Separation Agreement"), providing for severance benefits consistent with a termination of employment without "Cause" (as defined in Mr. Bonick's Amended and Restated Employment Agreement with AHS, effective as of January 10, 2025 (the "Employment Agreement")).
- Accordingly, pursuant to the terms of the Employment Agreement, as preserved by the Separation Agreement, the Company has recharacterized Mr. Bonick's separation as of the Separation Date as a termination for "Cause." The Board's final determination followed a review by the Board where it determined that Mr. Bonick failed to disclose fully to the Board and the Company compensation received from third parties otherwise required to be reported by Company policies.
- The Company has determined that none of the Company's financial statements or previously disclosed financial results are required to be revised or corrected as a result of the foregoing.
Reported
Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.
- On June 2, 2026 (the "Effective Date"), the Board of Directors (the "Board") of Ardent Health, Inc. (the "Company") appointed Dave Caspers, who previously served as the Company's Chief Operating Officer, as the Company's President and Chief Executive Officer and as a member of the Board.
- Mr. Caspers, age 55, has served as the Company's Chief Operating Officer since March 31, 2025.
- Prior to joining the Company, Mr. Caspers served as chief stores officer at Leslie's, Inc. ("Leslie's"), a leading direct-to-consumer pool and spa care brand, from October 2023 to March 2025.
- Prior to that, Mr. Caspers served as the senior vice president of retail operations at Leslie's from May 2023 to October 2023.
- Prior to joining Leslie's, Mr. Caspers served as the vice president, omni channel retail healthcare operations for Walmart Inc., a multinational retailer, from August 2022 to May 2023, where he was responsible for the execution and results for Walmart Health, including overseeing large-scale healthcare systems and omnichannel care delivery, including responsibility for in-store clinics and virtual health services.
- From August 2015 through August 2022, Mr. Caspers held various roles for Banner Health, a large non-profit health system, including vice president healthcare operations, vice president special project BUMD, and vice president patient experience.
Reported
On March 24, 2026, Ardent Health, Inc. (the "Company") and Ethan Chernin determined that Mr. Chernin would no longer serve as President, Hospital Services and would depart the Company effective that day.
- The Company treated Mr. Chernin's departure from the Company as a "Qualifying Termination" pursuant to the Company's Executive Severance Plan (the "Severance Plan").
- Mr. Chernin will be entitled to receive severance and related benefits for such a separation, subject to compliance with the terms and conditions of the Severance Plan.
Tools for this story
Each opens in a new tab, filled in for Ardent Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
